Pfizer is licensing a promising investigational cancer medicine from a smaller company. This move improves the drugmaker's ...

Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art ...

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

With COVID-19 still an ongoing global threat, Kennedy's policies are not only dangerously anti-scientific but actively ...

BEL, DLF, PI Inds, Petronet LNG, NLC India, Gujarat Gas, IRB Infrastructure, New India Assurance, Power Grid, Redington, ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Five-year follow-up data from the Phase 3 ARCHES trial shows XTANDI (enzalutamide) plus androgen deprivation therapy (ADT) reduces risk of death by 30% After a median follow-up of 61.4 months, ...

The case revolved around whether texts between a top official and a drug company executive counted as a public record that might need to be disclosed.

Hindustan Copper, Manappuram Finance and Titagarh Rail Systems shares are banned from F&O trading on 19 May 2025.

As New Zealand eyes a free trade agreement with India, experts say the next frontier could be pharmaceutical imports - ...